StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.63+0.34 (+4.10%)

Close on Nov 17, 2026Market cap $256.91MP/E –Yield –

Q32 Bio profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Q32 Bio's profit margin for the twelve months ending Jun 30, 2024 was -3068.7%. For fiscal 2025 it was 55.5%, against -156.0% the year before. The highest annual figure on record is 55.5% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202555.5%+211.5
FY2022Dec 31, 2022-156.0%+125.9
FY2021Dec 31, 2021-281.9%+4481.0
FY2020Dec 31, 2020-4762.9%+1474.5
FY2019Dec 31, 2019-6237.5%−5193.2
FY2018Dec 31, 2018-1044.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2023Sep 30, 2023-754.8%+3450.5
Q2 FY2023Jun 30, 2023-181.2%+3445.9
Q1 FY2023Mar 31, 2023-232.0%−11716.4
Q4 FY2022Dec 31, 2022-4276.2%−88.8
Q3 FY2022Sep 30, 2022-4205.2%−2380.1
Q2 FY2022Jun 30, 2022-3627.1%−2232.5
Q1 FY2022Mar 31, 202211484.4%+11488.1
Q4 FY2021Dec 31, 2021-4187.4%−1147.5
Q3 FY2021Sep 30, 2021-1825.2%+3154.0
Q2 FY2021Jun 30, 2021-1394.6%+4838.2
Q1 FY2021Mar 31, 2021-3.7%+6005.0
Q4 FY2020Dec 31, 2020-3039.9%+1252.6
Q3 FY2020Sep 30, 2020-4979.2%+1739.0
Q2 FY2020Jun 30, 2020-6232.8%+468.7
Q1 FY2020Mar 31, 2020-6008.7%+2825.4
Q4 FY2019Dec 31, 2019-4292.5%−2721.8
Q3 FY2019Sep 30, 2019-6718.1%−5835.0
Q2 FY2019Jun 30, 2019-6701.5%−5810.8
Q1 FY2019Mar 31, 2019-8834.1%−7929.1
Q4 FY2018Dec 31, 2018-1570.7%–
Q3 FY2018Sep 30, 2018-883.1%–
Q2 FY2018Jun 30, 2018-890.8%–
Q1 FY2018Mar 31, 2018-905.0%–

More Q32 Bio figures

See a number that looks wrong?